Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Teradata Corp
TDC
(Q1)Mar 31, 2010 | (FY)Dec 31, 2009 | (Q4)Dec 31, 2009 | (Q3)Sep 30, 2009 | (Q2)Jun 30, 2009 | (Q1)Mar 31, 2009 | (FY)Dec 31, 2008 | (Q4)Dec 31, 2008 | (Q3)Sep 30, 2008 | (Q2)Jun 30, 2008 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -56.60%184K | -82.43%133K | -82.43%133K | -84.34%382K | -92.22%167K | -95.88%424K | -94.11%757K | -94.11%757K | -84.79%2.44M | -67.48%2.15M |
-Cash and cash equivalents | -56.60%184K | -82.43%133K | -82.43%133K | -84.34%382K | -92.22%167K | -95.88%424K | -94.11%757K | -94.11%757K | -84.79%2.44M | -67.48%2.15M |
Receivables | ---- | ---- | ---- | --100K | ---- | ---- | ---- | ---- | ---- | -85.58%28K |
-Accounts receivable | ---- | ---- | ---- | --100K | ---- | ---- | ---- | ---- | ---- | -85.58%28K |
Inventory | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -96.03%587K | -76.03%3.81M |
Prepaid assets | ---- | ---- | ---- | -92.31%16K | -69.15%62K | --83K | ---- | ---- | -65.09%208K | -43.63%201K |
Other current assets | ---- | -62.12%100K | -62.12%100K | ---- | -52.33%133K | --108K | --264K | --264K | --108K | -72.21%279K |
Total current assets | -70.08%184K | -77.18%233K | -77.18%233K | -85.10%498K | -94.40%362K | -97.40%615K | -96.34%1.02M | -96.34%1.02M | -90.89%3.34M | -77.29%6.46M |
Non current assets | ||||||||||
Net PPE | ---- | ---- | ---- | --0 | --0 | -95.60%46K | ---- | ---- | -94.05%70K | -89.90%112K |
-Gross PPE | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -26.26%2.24M | -23.18%2.29M |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -16.48%-2.17M | -16.48%-2.17M |
Total non current assets | --0 | --0 | --0 | --0 | --0 | -98.18%46K | -98.19%51K | -98.19%51K | -97.65%70K | -96.38%112K |
Total assets | -72.16%184K | -78.26%233K | -78.26%233K | -85.40%498K | -94.49%362K | -97.48%661K | -96.51%1.07M | -96.51%1.07M | -91.40%3.41M | -79.16%6.58M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -39.52%75K | -2.56%114K | -2.56%114K | -79.32%284K | -86.09%203K | -89.78%124K | -90.84%117K | -90.84%117K | 26.42%1.37M | 2.15%1.46M |
-accounts payable | -39.52%75K | -2.56%114K | -2.56%114K | -79.32%284K | -86.09%203K | -89.78%124K | -90.84%117K | -90.84%117K | 26.42%1.37M | 2.15%1.46M |
Current accrued expenses | -14.49%59K | -64.38%26K | -64.38%26K | -86.21%28K | -94.70%88K | -96.26%69K | -96.61%73K | -96.61%73K | -93.84%203K | -55.78%1.66M |
Current deferred liabilities | ---- | ---- | ---- | ---- | -92.42%200K | -95.53%200K | ---- | ---- | -82.18%1.19M | -67.76%2.64M |
Other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --389K | --389K | --187K | --247K |
Current liabilities | -65.90%134K | -75.82%140K | -75.82%140K | -89.45%312K | -91.82%491K | -97.85%393K | -97.18%579K | -97.18%579K | -89.20%2.96M | -79.60%6.01M |
Non current liabilities | ||||||||||
Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- | ---- |
Total liabilities | -65.90%134K | -75.82%140K | -75.82%140K | -89.45%312K | -91.82%491K | -97.85%393K | -97.18%579K | -97.18%579K | -89.20%2.96M | -90.92%6.01M |
Shareholders'equity | ||||||||||
Share capital | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | -0.30%1K | -99.98%1K |
-common stock | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | -0.30%1K | 284.62%1K |
Retained earnings | -0.38%-91.93M | -0.63%-91.89M | -0.63%-91.89M | -0.66%-91.8M | -1.14%-92.02M | -9.40%-91.59M | -12.48%-91.32M | -12.48%-91.32M | -15.49%-91.2M | -35.03%-90.98M |
Paid-in capital | 0.14%91.98M | 0.19%91.98M | 0.19%91.98M | 0.36%91.98M | 0.37%91.89M | 0.29%91.85M | 0.46%91.81M | 0.46%91.81M | 0.43%91.65M | 218.25%91.55M |
Total stockholders'equity | -81.34%50K | -81.14%93K | -81.14%93K | -59.12%186K | -122.67%-129K | -96.60%268K | -95.17%493K | -95.17%493K | -96.30%455K | 101.64%569K |
Total equity | -81.34%50K | -81.14%93K | -81.14%93K | -59.12%186K | -122.67%-129K | -96.60%268K | -95.17%493K | -95.17%493K | -96.30%455K | 101.64%569K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |